Linked here is a PDF copy of my analysis of Citigroup Inc. (C) (alt.1, alt.2). Below are some highlights from the above linked analysis:
Company Description: Citigroup, Inc., a multibank holding company, provides various financial services to customers in the United States and internationally.
Fair Value: I consider four calculations of fair value, see page 2 of the linked PDF for a detailed description: 1.) Avg. High Yield Price, 2.) 20-Year DCF Price, 3.) Avg. P/E Price and 4.) Graham Number. Grand Slam Homerun! C is trading at a discount to ALL four valuations listed above. If I exclude the high and low valuation, and average the remaining two valuations, C is trading at an astounding 46.7% discount. C gets a Star for being fairly valued.
Dividend Analytical Data: In this section I consider five factors, see page 2 of the linked PDF for a detailed description: 1.) Rolling 4-yr Div. > 15%, 2.) Dividend Growth Rate, 3.) Years of Div. Growth, 4.) 1-Yr. > 5-Yr Growth and 5.) Payout 15% of avg. C scored a double in this section, earning 3 of the 4 available Stars, missing out only on 4.) above. Also, C failed the 5.) payout test since it's latest full-year payout % was 15 points (15%) higher than the latest 10-year average.
Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA)? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description: 1.) NPV MMA Diff. and 2.) Years to >MMA. Yet another strong performance for C. It earned the maximum two Stars available in this section.
Other: C, like most large banks, has suffered as a result of the sub-prime meltdown. I will not rehash it here today.
Conclusion: C earned one Star in the Fair Value section, a net of two Stars in the Dividend Analytical Data section and two Stars in the Dividend Income vs. MMA section for a total of Five Stars, which rates it as a 5-Star Strong Buy. Am I buying? No way, I have recently sold! I will explain why in post three of this series.
Disclaimer: As always this is only my opinion and you should not rely on it. Before buying or selling any stock you should do your own research and reach your own conclusion. See my Disclaimer for more information.
Full Disclosure: At the time of this writing, I own shares of C in my IRA.
What are your thoughts on C? Are you buying, selling or holding?
This post is the first in a three part series.
Recent Stock Analyses:
Popular Posts - Last 7 days
Presented below are my dividend stock and ETF/CEF holdings. This is not a recommendation to buy these securities. I have classified some of...
Simple interest is where interest is calculated on the original principal amount and unpaid interest is not added to the principal for futur...
My goals were originally defined in this December 1, 2007 Investing Goals post and last updated in my 2014 Investing Goals . Like last year...
Throughout history there have always been great companies that stand head-and-shoulders above their peers and the competition. They are lov...
Each Sunday I highlight any notable articles that I came across over the past week, along with any Carnivals I participated in. For those re...
Linked here is a detailed quantitative analysis of Cardinal Health, Inc. (CAH). Below are some highlights from the above linked analysis: ...
Linked here is a detailed quantitative analysis of Chevron Corporation (CVX). Below are some highlights from the above linked analysis: C...
Once again it is time for a goals/progress update. I am pleased to report that annualized dividend income increased in November, extending ...
Monday, October 31, 2011 will mark my fourth full year of writing as Dividends4Life . It is hard to believe another year has passed. Like th...
Like many that came before me, I am on a journey to construct a portfolio that will provide me... Dividends 4 Life